2

21stBio

📍 Søborg, DK
🏷️ vc
Visit Website ↗
Investment Thesis

21st.BIO specializes in delivering precision fermentation technology to accelerate the production of sustainable proteins and peptides. Their platform bridges the gap between lab innovation and industrial-scale manufacturing, leveraging expertise from Novo Nordisk and Novonesis. They offer shared development programs for nature-identical molecules and bespoke projects for exclusive protein assets, enabling faster, lower-risk market entry for partners.

Stage Focus
Not explicitly mentioned, but focuses on upscaling and industrial production, suggesting late-seed to growth stages.

Preferred startup development maturity for initial funding deployment.

Sectors & Themes

Precision fermentation technology platform for proteins and peptides, enabling scalable biomanufacturing

Core thematic spaces, technologies, and target market segments of interest.

Check Size Range
N/A

Standard financial allocation per investment round.

Outreach & Dossier Intelligence

Direct Verification Contact Email Pattern

[email protected] | [email protected]

Thesis Dossier Analysis Scorecard

Our agent analyzer scanned portfolio holdings and verified absolute match parameters...

Unlock Verified Partner Contacts

Find verified email templates, direct outreach copy created by AI, and calculate exact thesis match scores with 1-click.

Create Free Account to Unlock

Takes less than 30 seconds · No card required